| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 08/17/2005 | CN1655823A Topically applicable pharmaceutical preparation |
| 08/17/2005 | CN1655819A Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 08/17/2005 | CN1655808A Compositions for treating and/or preventing pollinosis |
| 08/17/2005 | CN1655786A Combination of a DPP IV inhibitor and a cardiovascular compound |
| 08/17/2005 | CN1655783A Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative |
| 08/17/2005 | CN1655782A Ophthalmological use of roflumilast for the treatment of diseases of the eye |
| 08/17/2005 | CN1655774A Bis-aromatic alkanols |
| 08/17/2005 | CN1655764A Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease |
| 08/17/2005 | CN1654657A Novel streptococcus antigens |
| 08/17/2005 | CN1654044A Chinese medicine for treating otitis media and its preparation |
| 08/17/2005 | CN1215069C Sulfonamicles and derivatives thereof that moulate the activity of endothelin |
| 08/17/2005 | CN1214815C Composition for stabilizing corneal tissue during or after orthokeratology lens wear |
| 08/17/2005 | CN1214790C Method for preparing isoxazole substituted composition for treating inflammation |
| 08/17/2005 | CN1214788C Compositions for treatment and prevention of cardiovascular diseases |
| 08/17/2005 | CN1214785C Eyes-protecting transdermal acupoint plaster and it preparation method |
| 08/16/2005 | US6930118 3-Oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives |
| 08/16/2005 | US6930108 Nitrogen compounds such as 2-[2-ethoxy-5-(4-ethyl-piperazine-1-sulphonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one, used for prophylaxis of psoriasis, diabetes, alopecia, genetic, sexual, cardiovascular or genetic disorders |
| 08/16/2005 | CA2342974C Methods and compositions for inhibition of angiogenesis |
| 08/16/2005 | CA2094859C Anticonvulsant fructopyranose cyclic sulfites and sulfates |
| 08/11/2005 | WO2005072768A1 Preventive and/or remedy for retinopathy |
| 08/11/2005 | WO2005072066A2 Preventive or therapeutic agent for diabetic maculopathy |
| 08/11/2005 | US20050176964 Nicotinamide derivatives useful as p38 inhibitors |
| 08/11/2005 | US20050176931 Eotaxin : eosinophil chemotactic cytokine |
| 08/11/2005 | US20050176927 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; diagnosis |
| 08/11/2005 | US20050176828 Polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; antiproliferative agents; inhibition of cellular polyamine synthesis, even in the presence of exogenously supplied spermidine to inhibit cell growth and proliferation |
| 08/11/2005 | US20050176813 Modulating the potassium ion channel activity of T-cells; autoimmune and inflammatory diseases such as multiple sclerosis, rheumatoid arthritis or transplant rejection; synthesis by reaction of an acetophenone such as khellinone with an aryl aldehyde |
| 08/11/2005 | US20050176800 Preterm labor, dysmenorrhea, asthma, hypertension, fertility disorder, sexual dysfunction, undesired blood clotting, bone disorders, preeclampsia or eclampsia, or an eosinophil disorder; use with phosphodiesterase inhibitors; e.g. 7-[(2R,3R)-3-Chloro-1-(4-hydroxynonyl)-pyrrolidin-2-yl]-hept-5-enoic acid |
| 08/11/2005 | US20050176770 Novel 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them |
| 08/11/2005 | US20050176765 For therapy of glaucoma, dementia such as Alzheimer's disease and vascular dementia, depression, attention deficit disorder, sleep disorder, schizophrenia, pain, ischemia; -[1-[1-(3-Thienoyl)piperidin-4-yl]piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one |
| 08/11/2005 | US20050176762 Tachykinin receptor subtypes NK3 and NK2 (NK neurokinin); various diseases including respiratory system disorders, autoimmune disorders, psychological disorders, skin disorders |
| 08/11/2005 | US20050176756 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted |
| 08/11/2005 | US20050176753 controlling signal transduction; anticancer agents; antitumor agnets; atherosclerosis; vision defects; antidiabetic agents; antiinflammatory agents |
| 08/11/2005 | US20050176751 Selective H1 histamine receptor antagonists; bronchial asthma, allergic rhinitis, conjunctivitis, dermatitis, urticaria and other allergic diseases; e.g. 3-(4-[1-(2-methoxyethyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]piperidin-1-ylmethyl)benzoic acid |
| 08/11/2005 | US20050176731 N-[5-({(2S)-3-[(4-{4-[(4-benzylpiperidin-1-yl)carbonyl]phenyl}cyclohexyl)amino]-2-hydroxypropyl}oxy)-2-hydroxyphenyl]methanesulfonamide; beta 3 receptors agonist; gastrointestinal diseases; antiobesity, antidiabetic, cicatrizing agents, tocolytics, dysmenorrhea, antiglaucomatous; amidation |
| 08/11/2005 | US20050176723 (Halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 08/11/2005 | US20050176722 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 08/11/2005 | US20050176714 Pyridazine derivatives |
| 08/11/2005 | US20050176711 Phthalazine derivatives for treating inflammatory diseases |
| 08/11/2005 | US20050176708 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 08/11/2005 | US20050176704 Hydroxymorpholinone derivative and medicinal use thereof |
| 08/11/2005 | US20050176700 (2-methoxyphenyl)acetic acid-7-{4-[3-(2-methoxybenzyloxy)-propoxy]phenyl}-3-(2-thiophen-2-ylacetyl)-3,9-diazabicyclo[3.3.1]non-6-en-6-yl-methyl ester; metabolically stable, orally bioavailable and sufficiently soluble; industrial scale; non-peptidic nature, low molecular weight |
| 08/11/2005 | US20050176123 Protease inhibitor |
| 08/11/2005 | US20050175613 Compositions and methods for treating hyperimmune response in the eye |
| 08/11/2005 | CA2553387A1 Piperidinyl prostaglandin e analogs |
| 08/10/2005 | EP1560589A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 08/10/2005 | EP1560586A1 The use of an anti-allergy agent and a steroid to treat allergic rhinitis |
| 08/10/2005 | EP1560540A2 Methods of treating dry eye disease with lantibiotics |
| 08/10/2005 | EP1339679B1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 08/10/2005 | EP1331931B1 Treatment of tinnitus |
| 08/10/2005 | EP1292581B1 Bicyclic cyclohexylamines and their use as nmda receptor antagonists |
| 08/10/2005 | EP1289740B1 Crystalline polymeric compositions for ophthalmic devices |
| 08/10/2005 | EP1228028B1 Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders |
| 08/10/2005 | EP1208103B1 Reverse-turn mimetics and methods relating thereto |
| 08/10/2005 | EP0894009B1 Improved vision through photodynamic therapy of the eye |
| 08/10/2005 | EP0833622B1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 08/10/2005 | CN1653125A Amelioration of the development of cataracts and other ophthalmic diseases |
| 08/10/2005 | CN1653084A Mutants of the P4 protein of nontypable haemophilus influenzae with reduced enzymatic activity |
| 08/10/2005 | CN1653075A C-aryl glucoside SGLT2 inhibitors and method |
| 08/10/2005 | CN1653059A Macrocyclic compounds useful as pharmaceuticals |
| 08/10/2005 | CN1653046A 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
| 08/10/2005 | CN1653045A 8-azaprostaglandin analogs as agents for lowering intraocular pressure |
| 08/10/2005 | CN1653042A Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 08/10/2005 | CN1653036A Amino acids with affinity for the alpha-2-delta-protein |
| 08/10/2005 | CN1652788A Method of treating diabetes |
| 08/10/2005 | CN1652782A Nicotinamide derivatives useful as PDE4 inhibitors |
| 08/10/2005 | CN1652779A Treatment of chemokine mediated diseases |
| 08/10/2005 | CN1652777A Combination of organic compounds |
| 08/10/2005 | CN1652776A N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 08/10/2005 | CN1651431A Inhibitors of alpha L beta 2 mediated cell adhesion |
| 08/10/2005 | CN1651090A Transmission system of medicine containing trehalose and hyaluronic acid for eye part and its preparation method |
| 08/10/2005 | CN1650998A Preparation method of Chinese medicinal eye drops for treating myopia |
| 08/10/2005 | CN1650863A Antibiotic compositions for treatment of the eye, ear and nose |
| 08/10/2005 | CN1214114C Activatable recombinant neurotoxins |
| 08/10/2005 | CN1214026C Indol-3-yl derivatives |
| 08/10/2005 | CN1214022C Vitamin D analogues |
| 08/10/2005 | CN1214017C 四唑衍生物 Tetrazole derivatives |
| 08/10/2005 | CN1214008C Therapeutic biaryl derivatives |
| 08/10/2005 | CN1214007C Cyclopentanoindoles, compositions containing such compounds and methods of treatment |
| 08/10/2005 | CN1213999C Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents |
| 08/10/2005 | CN1213980C Vitamin D analogues |
| 08/10/2005 | CN1213757C Combinations for treatment of DNA viral infections |
| 08/09/2005 | US6927303 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 08/09/2005 | US6927234 possessing anti-cancer activity, anti-inflammatory activity, anti-obesity activity, and/or hair growth promotion activity |
| 08/09/2005 | US6927222 Compounds |
| 08/09/2005 | US6927219 Secondary amides such as N-Adamantan-1-methyl-2-chloro-5-(3,5-dioxo-4,5-dihydro-3H- (1,2,4)triazin-2-yl)-benzamide used as antagonists for biological receptors; antiinflammatiory, anticarcinogenic or antiischemic agents |
| 08/09/2005 | US6927218 Aryl N-cyanoguanidines and methods related thereto |
| 08/09/2005 | US6926898 Albumin fusion proteins |
| 08/04/2005 | WO2004007457A3 Substituted benzylamine derivatives and methods of use |
| 08/04/2005 | US20050171350 Benzhydryl derivatives |
| 08/04/2005 | US20050171214 Utilizing astaxanthin and/or ester as food and/or drink nutritional supplement; supporting and restoring human eyes automatic focusing ability |
| 08/04/2005 | US20050171188 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 08/04/2005 | US20050171187 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate |
| 08/04/2005 | US20050171174 Inhibitors of alpha l beta 2 integrin mediated cell adhesion |
| 08/04/2005 | US20050171134 such as 4-[4-(1-Amino-1-methylethyl)phenyl]-5-chloro-N-[4-(2-hydroxyethyl)phenyl]pyrimidine-2-amine used as tyrosine kinase inhibitors, for prophylaxis disease states associated with angiogenesis |
| 08/04/2005 | US20050171129 Polycyclic guanine derivative phosphodiesterase V inhibitors |
| 08/04/2005 | US20050171125 Novel alkoxypyridine-derivatives |
| 08/04/2005 | US20050171111 E.g., 4-[[5-[[4-(3-chlorophenyl)-1,2-dihydro-2-oxo-6-quinolinyl]hydroxymethyl]-1H-imidazol-1-yl]methyl]-benzonitrile; prevents the membrane attachment of p21ras and blocks the aberrant growth of ras-transformed tumors |
| 08/04/2005 | US20050171096 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE) |
| 08/04/2005 | US20050171092 Chemical compounds |
| 08/04/2005 | US20050171091 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors |